Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Modulating the alveolar milieu to enhance resolution of fibrotic lung injury.

Garcia O, Buckley S, Navarro S, Driscoll B, Warburton D.

Proc Am Thorac Soc. 2012 Jul;9(3):117-9. doi: 10.1513/pats.201201-013AW.

2.

Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis.

Serrano-Mollar A, Nacher M, Gay-Jordi G, Closa D, Xaubet A, Bulbena O.

Am J Respir Crit Care Med. 2007 Dec 15;176(12):1261-8. Epub 2007 Jul 19.

3.

β-catenin in the alveolar epithelium protects from lung fibrosis after intratracheal bleomycin.

Tanjore H, Degryse AL, Crossno PF, Xu XC, McConaha ME, Jones BR, Polosukhin VV, Bryant AJ, Cheng DS, Newcomb DC, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE.

Am J Respir Crit Care Med. 2013 Mar 15;187(6):630-9. doi: 10.1164/rccm.201205-0972OC. Epub 2013 Jan 10.

4.

Stem cells and pulmonary fibrosis: cause or cure?

McNulty K, Janes SM.

Proc Am Thorac Soc. 2012 Jul;9(3):164-71. doi: 10.1513/pats.201201-010AW.

PMID:
22802292
5.

Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.

Garcia O, Carraro G, Turcatel G, Hall M, Sedrakyan S, Roche T, Buckley S, Driscoll B, Perin L, Warburton D.

PLoS One. 2013 Aug 13;8(8):e71679. doi: 10.1371/journal.pone.0071679. eCollection 2013.

6.

Conceptual approaches to lung injury and repair.

Zemans RL, Henson PM, Henson JE, Janssen WJ.

Ann Am Thorac Soc. 2015 Mar;12 Suppl 1:S9-15. doi: 10.1513/AnnalsATS.201408-402MG. Review.

7.

Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling.

Ito Y, Correll K, Schiel JA, Finigan JH, Prekeris R, Mason RJ.

Am J Physiol Lung Cell Mol Physiol. 2014 Jul 1;307(1):L94-105. doi: 10.1152/ajplung.00233.2013. Epub 2014 Apr 18.

8.

Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair.

Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, Williams ED, Jenkin G, Wallace E, Trounson A, Manuelpillai U.

Am J Respir Crit Care Med. 2010 Sep 1;182(5):643-51. doi: 10.1164/rccm.201001-0014OC. Epub 2010 Jun 3.

PMID:
20522792
9.

Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury.

Shyamsundar M, McAuley DF, Ingram RJ, Gibson DS, O'Kane D, McKeown ST, Edwards A, Taggart C, Elborn JS, Calfee CS, Matthay MA, O'Kane CM.

Am J Respir Crit Care Med. 2014 Jun 15;189(12):1520-9. doi: 10.1164/rccm.201310-1892OC.

10.

Mechanisms of alveolar epithelial injury, repair, and fibrosis.

Chambers RC, Mercer PF.

Ann Am Thorac Soc. 2015 Mar;12 Suppl 1:S16-20. doi: 10.1513/AnnalsATS.201410-448MG. Review.

11.

Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema.

Li Y, Gu C, Xu W, Yan J, Xia Y, Ma Y, Chen C, He X, Tao H.

Respir Res. 2014 Oct 16;15:120. doi: 10.1186/s12931-014-0120-3.

12.

Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells.

Spitalieri P, Quitadamo MC, Orlandi A, Guerra L, Giardina E, Casavola V, Novelli G, Saltini C, Sangiuolo F.

Eur Respir J. 2012 Feb;39(2):446-57. doi: 10.1183/09031936.00005511. Epub 2011 Jun 30.

13.

Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis.

Sisson TH, Mendez M, Choi K, Subbotina N, Courey A, Cunningham A, Dave A, Engelhardt JF, Liu X, White ES, Thannickal VJ, Moore BB, Christensen PJ, Simon RH.

Am J Respir Crit Care Med. 2010 Feb 1;181(3):254-63. doi: 10.1164/rccm.200810-1615OC. Epub 2009 Oct 22.

14.

Alveolar epithelial cells: differentiation and lung injury.

Sugahara K, Tokumine J, Teruya K, Oshiro T.

Respirology. 2006 Jan;11 Suppl:S28-31.

PMID:
16423267
15.

Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms.

Akram KM, Samad S, Spiteri MA, Forsyth NR.

Respir Res. 2013 Jan 25;14:9. doi: 10.1186/1465-9921-14-9.

16.

Alveolar type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis.

Guillamat-Prats R, Gay-Jordi G, Xaubet A, Peinado VI, Serrano-Mollar A.

J Heart Lung Transplant. 2014 Jul;33(7):758-65. doi: 10.1016/j.healun.2014.03.008. Epub 2014 May 17.

PMID:
25023067
17.

Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis.

Ohta H, Chiba S, Ebina M, Furuse M, Nukiwa T.

Am J Physiol Lung Cell Mol Physiol. 2012 Jan 15;302(2):L193-205. doi: 10.1152/ajplung.00349.2010. Epub 2011 Oct 14.

18.

Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis.

Germano D, Blyszczuk P, Valaperti A, Kania G, Dirnhofer S, Landmesser U, Lüscher TF, Hunziker L, Zulewski H, Eriksson U.

Am J Respir Crit Care Med. 2009 May 15;179(10):939-49. doi: 10.1164/rccm.200809-1390OC. Epub 2009 Feb 20.

PMID:
19234103
19.

Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis.

Banerjee ER, Henderson WR Jr.

Stem Cell Res Ther. 2012 May 29;3(3):21. doi: 10.1186/scrt112.

20.

Supplemental Content

Support Center